... "window" encourages more startups to consider going public and prepare for listings. Mega Rounds and New "Unicorns": Investments Hit Record Heights The artificial intelligence sector remains the main driver of the venture boom in 2025, setting new records for funding amounts. Investors worldwide are eager to invest in AI leaders, directing colossal sums into the most promising projects. Literally every week, new mega rounds are announced, confirming AI's status as the primary "magnet" for venture capital. For instance,...

... revolution. Artificial intelligence is flooding the fintech sector, leaving traditional business models with little chance of survival. Mega-funds are re-entering the market, bringing fresh capital and ambitious projects. While the Middle East attracts new investors with its promising startups, Southeast Asia demonstrates impressive growth in venture deals. Africa is becoming the new hotspot for fintech initiatives, and Russia surprises with a surge of startups in the most unexpected niches. The 2025 IPO ...

... cryptocurrency companies and develop the Web3 sector. The global trend is clear: governments are attempting to integrate cryptocurrencies into the existing financial system through understandable rules. In the long run, this reduces legal risks for investors and opens new opportunities for large institutions wishing to engage with digital assets. Institutional Investments Hit Record Highs Large investors continue to increase their presence in digital assets at unprecedented rates . According to a recent report from ...

... services and insurance segment (via Aetna), but profits are projected to decrease year-on-year by ~10-20%, primarily due to increased medical expenses and costs associated with recent acquisitions. Last quarter, CVS reduced its earnings forecast, so investors will focus on new guidance from management. A key driver of the report will be the effectiveness of cost-cutting measures (including closing some stores and layoffs) and trends in the prescription drug segment. Any positive surprises related to earnings or an upward ...

... High EPS projections ($0.82) imply improving margins, and confirming this trend (e.g., through scaling production or pricing) would be an additional positive. However, if growth slows more than expected or if the company encounters delays in getting new devices approved, investors may react negatively—Penumbra shares trade at a premium and are sensitive to growth rates. Overall, the medtech sector is currently attractive, and Penumbra, with a stable report, will confirm its reputation as a rapidly growing innovative ...